0
Articles   |    
A Potential Clinical Use for Methylphenidate with Tricyclic Antidepressants
RALPH N. WHARTON; JAMES M. PEREL; PETER G. DAYTON; SIDNEY MALITZ
Am J Psychiatry 1971;127:1619-1625.
View Article Information
Assistant Professor of Psychiatry, Columbia University College of Physicians and Surgeons, New York, N.Y.
Associate Professor, Clinical Pharmacology Group, Emory University School of Medicine, Atlanta, Ga.
1971, American Psychiatric Association
text A A A
PDF of the full text article.
Abstract
Seven patients with recurrent refractory psychotic depressive illness were treated with tricyclic antidepressants plus methylphenidate (Ritalin). The effect of methylphenidate appears to involve an increase in the blood levels of antidepressants through enzymatic inhibition of the metabolism of imipramine and desmethylimipramine that is concomitant with clinical improvement. The potentiation by methylphenidate may have important implications for the treatment of depression.Abstract Teaser
Figures in this Article

    Your Session has timed out. Please sign back in to continue.
    Sign In Your Session has timed out. Please sign back in to continue.
    Sign In to Access Full Content
     
    Username
    Password
    Sign in via Athens (What is this?)
    Athens is a service for single sign-on which enables access to all of an institution's subscriptions on- or off-site.
    Not a subscriber?

    Subscribe Now/Learn More

    PsychiatryOnline subscription options offer access to the DSM-IV-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

    Need more help? PsychiatryOnline Customer Service may be reached by emailing PsychiatryOnline@psych.org or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

    +
    +
    +

    CME Activity

    There is currently no quiz available for this resource. Please click here to go to the CME page to find another.
    Submit a Comments
    Please read the other comments before you post yours. Contributors must reveal any conflict of interest.
    Comments are moderated and will appear on the site at the discertion of JBJS editorial staff.

    * = Required Field
    (if multiple authors, separate names by comma)
    Example: John Doe



    Related Content
    Articles
    Books
    What Your Patients Need to Know About Psychiatric Medications, 2nd Edition > Chapter 29.  >
    What Your Patients Need to Know About Psychiatric Medications, 2nd Edition > Chapter 66.  >
    What Your Patients Need to Know About Psychiatric Medications, 2nd Edition > Chapter 68.  >
    What Your Patients Need to Know About Psychiatric Medications, 2nd Edition > Chapter 69.  >
    What Your Patients Need to Know About Psychiatric Medications, 2nd Edition > Chapter 70.  >
    Topic Collections
    Psychiatric News
    PubMed Articles